Ranbaxy Generic Drug Antitrust – In re: Ranbaxy Generic Drug Antitrust Litig., No. 1:19-cv-10356 (D. Mass.)
Lowey Dannenberg is prosecuting a class action, on behalf of a class of third-party payers, alleging that Ranbaxy, one of the world’s largest generic…
Read More
